← Leaderboards
Brian G. Pierce
Univ Of Maryland, College Park
$5,043,672
Attributed
$15,532,039
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,532,039 · 7
By mechanism
R01$13,002,612 · 3
R21$1,288,380 · 3
R35$1,241,047 · 1
Top collaborators
- Roy A Mariuzza14 shared
- Thomas R Fuerst12 shared
- Alexander Andrianov10 shared
- Steven Foung7 shared
- Gilad A Ofek5 shared
- Alexander Ploss5 shared
- Nevil John Singh5 shared
- Eric A Toth2 shared
Most similar at Univ Of Maryland, College Park
Same institution · by research overlap
- Thomas R Fuerst$2,156,141
- Alexander Andrianov$2,015,325
- Gilad A Ofek$1,245,217
- Ian M White$6,468,344
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesDesignStructureVirusAntigensImmune ResponseMolecular ConformationEpitopesBindingComplexImmunitySpecificityResponseNeutralizing AntibodyResolutionVariantFlexibilityViralAffinityMediatingT-LymphocyteHepatitis C VaccineB-LymphocytesGlycoproteins
Grant awards (24)
Rational design and efficacy testing of vaccines against HCV$1,357,012
R01 · FY2025 · AI
High resolution modeling and design of immune recognition$344,116
R35 · FY2025 · GM · contact PI
Rational design and efficacy testing of vaccines against HCV$1,410,043
R01 · FY2024 · AI
High resolution modeling and design of immune recognition$344,116
R35 · FY2024 · GM · contact PI
Structural Basis for T Cell Recognition of SARS-CoV-2$193,671
R21 · FY2024 · AI
Rational design and efficacy testing of vaccines against HCV$179,958
R01 · FY2024 · AI
Rational design and efficacy testing of vaccines against HCV$1,379,680
R01 · FY2023 · AI
High resolution modeling and design of immune recognition$344,116
R35 · FY2023 · GM · contact PI
Structural Basis for T Cell Recognition of SARS-CoV-2$232,710
R21 · FY2023 · AI
Rational design and efficacy testing of vaccines against HCV$1,410,544
R01 · FY2022 · AI
High resolution modeling and design of immune recognition$208,699
R35 · FY2022 · GM · contact PI
Structure-Based Vaccine Design for Hepatits C Virus$1,120,994
R01 · FY2021 · AI
High Resolution Modeling and Design of T-Cell Receptors$321,398
R01 · FY2021 · GM · contact PI
Design of immunologically intact soluble HCV E1E2 complexes using transmembrane-mimic scaffolds$230,519
R21 · FY2021 · AI · contact PI
Structure-Based Vaccine Design for Hepatits C Virus$1,128,779
R01 · FY2020 · AI
High Resolution Modeling and Design of T-Cell Receptors$321,599
R01 · FY2020 · GM · contact PI
Design of immunologically intact soluble HCV E1E2 complexes using transmembrane-mimic scaffolds$191,930
R21 · FY2020 · AI · contact PI
Structure-Based Vaccine Design for Hepatits C Virus$1,136,335
R01 · FY2019 · AI
High Resolution Modeling and Design of T-Cell Receptors$321,795
R01 · FY2019 · GM · contact PI
Structure-Based Vaccine Design for Hepatits C Virus$1,142,860
R01 · FY2018 · AI
High Resolution Modeling and Design of T-Cell Receptors$321,985
R01 · FY2018 · GM · contact PI
Structure-Based Vaccine Design for Hepatits C Virus$1,449,630
R01 · FY2017 · AI
Structure-based HCV vaccine design$193,150
R21 · FY2017 · AI
Structure-based HCV vaccine design$246,400
R21 · FY2016 · AI